| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2019 | VERASCI, LLC | 3211 SHANNON RD | DURHAM | NC | 27707-6324 | DURHAM | USA | U01FD006872 | Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia | 000 | 1 | FDA | 12/5/2022 | $0 |
| | 2023 | 2018 | VERASCI, LLC | 3211 SHANNON RD | DURHAM | NC | 27707-6324 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 6 | NIH | 2/2/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = -$19,815 ) |
| | 2022 | 2019 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG058345 | Validation of a Performance Based Measure of Functioning in MCI and Early AD | 000 | 3 | NIH | 2/16/2022 | $0 |
| | 2022 | 2018 | VERASCI, LLC | 3211 SHANNON RD | DURHAM | NC | 27707-6324 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 6 | NIH | 7/11/2022 | -$19,815 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | U01FD006872 | Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia | 000 | 1 | FDA | 7/27/2021 | $0 |
| | 2021 | 2019 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG058345 | Validation of a Performance Based Measure of Functioning in MCI and Early AD | 000 | 3 | NIH | 3/15/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | U01FD006872 | Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia | 000 | 1 | FDA | 7/24/2020 | $0 |
| | 2020 | 2018 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 6 | NIH | 9/16/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $947,628 ) |
| | 2019 | 2019 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | U01FD006872 | Qualitative Analysis of the Content Validity of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) in Schizophrenia | 000 | 1 | FDA | 9/3/2019 | $249,765 |
| | 2019 | 2019 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG058345 | Validation of a Performance Based Measure of Functioning in MCI and Early AD | 000 | 3 | NIH | 3/28/2019 | $697,863 |
| | 2019 | 2017 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG058345 | Validation of a Performance Based Measure of Functioning in MCI and Early AD | 001 | 1 | NIH | 5/9/2019 | $0 |
| | 2019 | 2017 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG053121 | Innovating Tablet-Based Cognitive Assessment for CNS Disorders of Aging | 000 | 2 | NIH | 5/13/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,600,961 ) |
| | 2018 | 2018 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG058345 | Validation of a Performance Based Measure of Functioning in MCI and Early AD | 000 | 2 | NIH | 3/5/2018 | $731,129 |
| | 2018 | 2018 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 6 | NIH | 8/1/2018 | $621,524 |
| | 2018 | 2018 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 001 | 6 | NIH | 9/13/2018 | $248,308 |
|
| Issue Date FY: 2017 ( Subtotal = $1,585,718 ) |
| | 2017 | 2017 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 5 | NIH | 7/15/2017 | $710,216 |
| | 2017 | 2017 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG053121 | Innovating Tablet-Based Cognitive Assessment for CNS Disorders of Aging | 000 | 2 | NIH | 5/5/2017 | $660,103 |
| | 2017 | 2017 | NCT HOLDINGS, INC. | 3211 SHANNON RD STE 300 | DURHAM | NC | 27707-6324 | DURHAM | USA | R44AG058345 | Validation of a Performance Based Measure of Functioning in MCI and Early AD | 000 | 1 | NIH | 9/15/2017 | $215,399 |
|
| Issue Date FY: 2016 ( Subtotal = $1,396,910 ) |
| | 2016 | 2016 | NEUROCOG TRIALS INC | 3211 SHANNON ROAD | DURHAM | NC | 27707 | DURHAM | USA | R44AG053121 | Innovating Tablet-Based Cognitive Assessment for CNS Disorders of Aging | 000 | 1 | NIH | 5/5/2016 | $711,254 |
| | 2016 | 2016 | NEUROCOG TRIALS INC | 3211 SHANNON ROAD | DURHAM | NC | 27707 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 4 | NIH | 7/28/2016 | $685,656 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2013 | NEUROCOG TRIALS INC | 3211 SHANNON ROAD | DURHAM | NC | 27707 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 3 | NIH | 4/7/2015 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $568,573 ) |
| | 2013 | 2013 | NEUROCOG TRIALS INC | 3211 SHANNON ROAD | DURHAM | NC | 27707 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 3 | NIH | 9/11/2013 | $568,573 |
|
| Issue Date FY: 2012 ( Subtotal = $584,321 ) |
| | 2012 | 2012 | NEUROCOG TRIALS INC | 3211 SHANNON ROAD | DURHAM | NC | 27707 | DURHAM | USA | R44MH084240 | The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) | 000 | 2 | NIH | 9/11/2012 | $584,321 |
|
| Issue Date FY: 2009 ( Subtotal = $137,176 ) |
| | 2009 | 2009 | NEUROCOG TRIALS INC | 3211 SHANNON ROAD | DURHAM | NC | 27707 | DURHAM | USA | R43MH084240 | COMPUTERIZED INTERACTIVE ASSESSMENT OF FUNCTIONAL SKILLS FOR SCHIZOPHRENIA DRUG T | 000 | 1 | NIH | 6/26/2009 | $137,176 |
|
|
